KGV-91504-20181
2 vaccinations
7 coded responses
21 check-ins
7 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 156 / PA
- Registered
- 2021-03-15
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-14
Dose 1 — Janssen/Johnson & Johnson
-
2021-03-15
Registered in v-safe
-
2021-03-15
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-03-17
Survey response — days 1–6 daily, dose 1MedDRA: Oropharyngeal pain — Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea, Abdominal painFree text: Sore throatMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-18
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal painAdult check-in
-
2021-03-19
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal painAdult check-in
-
2021-03-20
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal painAdult check-in
-
2021-03-21
Health check-in — day 7, dose 1Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness, Diarrhea, Abdominal pain, Rash, not including the immediate area around the injection siteAdult check-in
- 2021-04-04
- 2021-04-11
-
2021-04-18
Survey response — day 35, single doseMedDRA: Headache — Feeling: FairFree text: HeadachesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-25
- 2021-06-13
- 2021-09-12
-
2021-10-24
Dose 2 — Pfizer-BioNTechCo-administered: Flu
-
2021-11-01
Health check-in — day 7, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Muscle or body achesAdult check-in
-
2021-11-07
Survey response — day 14, dose 2MedDRA: Gastroenteritis viral — Feeling: Good · Be unable to work or attend schoolFree text: Stomach fluMedDRA releases: 2024-11 · check-in free text available
-
2021-11-14
Survey response — day 21, dose 2MedDRA: Abortion spontaneous — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visitFree text: MiscarriageMedDRA releases: 2024-11 · check-in free text available
-
2021-11-14
Report sent to call center — day 21, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Emergency room or emergency department visit · 1 call case(s)
- 2021-11-15
- 2021-11-21
- 2021-11-28
- 2021-12-05
-
2022-01-23
Survey response — 3 months, dose 2MedDRA: SARS-CoV-2 test positive, Taste disorder — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Inaccurate sense of taste. Positive COVID-19 rapid test.MedDRA releases: 2024-11 · check-in free text available
-
2022-04-24
Survey response — 6 months, dose 2MedDRA: Abdominal pain, Nausea — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Nausea, abdominal painMedDRA releases: 2024-11 · check-in free text available
-
2022-10-24
Survey response — 12 months, dose 2MedDRA: Influenza, Nasopharyngitis — Feeling: Good · Be unable to work or attend schoolFree text: Cold & flu symptomsMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-14 | Janssen/Johnson & Johnson | |
| 2 | 2021-10-24 | Pfizer-BioNTech | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-11-14 | Unsuccessful |
Free text
Release 5 — days 1–6 daily, dose 1
Systemic reaction (other): Sore throat
Release 7 — day 35, single dose
Symptoms: Headaches
Release 10 — day 14, dose 2
Symptoms: Stomach flu
Release 10 — day 21, dose 2
Symptoms: Miscarriage
Release 11 — 3 months, dose 2
Symptoms: Inaccurate sense of taste. Positive COVID-19 rapid test.
Release 11 — 6 months, dose 2
Symptoms: Nausea, abdominal pain
Release 12 — 12 months, dose 2
Symptoms: Cold & flu symptoms
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abdominal pain | · | · | ✓ |
| SD | Abortion spontaneous | · | · | ✓ |
| SD | Gastroenteritis viral | · | · | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Influenza | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SD | Taste disorder | · | · | ✓ |
| SRO | Oropharyngeal pain | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release